0001237899-12-000102.txt : 20121218
0001237899-12-000102.hdr.sgml : 20121218
20121218113109
ACCESSION NUMBER: 0001237899-12-000102
CONFORMED SUBMISSION TYPE: 4
PUBLIC DOCUMENT COUNT: 1
CONFORMED PERIOD OF REPORT: 20121214
FILED AS OF DATE: 20121218
DATE AS OF CHANGE: 20121218
ISSUER:
COMPANY DATA:
COMPANY CONFORMED NAME: REGENERON PHARMACEUTICALS INC
CENTRAL INDEX KEY: 0000872589
STANDARD INDUSTRIAL CLASSIFICATION: PHARMACEUTICAL PREPARATIONS [2834]
IRS NUMBER: 133444607
STATE OF INCORPORATION: NY
FISCAL YEAR END: 1231
BUSINESS ADDRESS:
STREET 1: 777 OLD SAW MILL RIVER RD
CITY: TARRYTOWN
STATE: NY
ZIP: 10591-6707
BUSINESS PHONE: 9143477000
REPORTING-OWNER:
OWNER DATA:
COMPANY CONFORMED NAME: McCorkle Douglas S
CENTRAL INDEX KEY: 0001403178
FILING VALUES:
FORM TYPE: 4
SEC ACT: 1934 Act
SEC FILE NUMBER: 000-19034
FILM NUMBER: 121270449
MAIL ADDRESS:
STREET 1: REGENERON PHARMACEUTICALS, INC.
STREET 2: 777 OLD SAW MILL RIVER ROAD
CITY: TARRYTOWN
STATE: NY
ZIP: 10591
4
1
edgardoc.xml
PRIMARY DOCUMENT
X0306
4
2012-12-14
0
0000872589
REGENERON PHARMACEUTICALS INC
REGN
0001403178
McCorkle Douglas S
777 OLD SAW MILL RIVER ROAD
TARRYTOWN
NY
10591
0
1
0
0
VP Controller & Asst Treasurer
Common Stock
2012-12-17
4
M
0
4000.0
16.8
A
4000.0
D
Common Stock
2012-12-17
4
M
0
800.0
16.8
A
4800.0
D
Common Stock
2012-12-17
4
S
0
800.0
179.45
D
4000.0
D
Common Stock
2012-12-17
4
M
0
200.0
16.8
A
4200.0
D
Common Stock
2012-12-17
4
S
0
200.0
178.19
D
4000.0
D
Common Stock
4008.0
I
By 401(k) Plan
Incentive Stock Option (right to buy)
16.8
2012-12-17
4
M
0
4000.0
D
2018-12-17
Common Stock
4000.0
1000.0
D
Incentive Stock Option (right to buy)
16.8
2012-12-17
4
M
0
800.0
D
2018-12-17
Common Stock
800.0
200.0
D
Incentive Stock Option (right to buy)
16.8
2012-12-17
4
M
0
200.0
D
2018-12-17
Common Stock
200.0
0.0
D
Non-Qualified Stock Option (right to buy)
179.13
2012-12-14
4
A
0
26000.0
A
2022-12-14
Common Stock
26000.0
26000.0
D
Disposition/acquisition made pursuant to a plan intended to comply with Rule 10b5-1(c).
Represents volume-weighted average price of sales of 800 shares of Company stock on December 17, 2012 at prices ranging from $179.02 to $179.94. Upon request by the Commission staff, the Company, or a security holder of the Company, the reporting person will provide full information regarding the number of shares sold by the reporting person on December 17, 2012 at each separate price.
Represents volume-weighted average price of sales of 200 shares of Company stock on December 17, 2012 at prices ranging from $178.06 to $178.32. Upon request by the Commission staff, the Company, or a security holder of the Company, the reporting person will provide full information regarding the number of shares sold by the reporting person on December 17, 2012 at each separate price.
The stock option award (combined incentive stock option and non-qualified stock option) vests in four equal annual installments, commencing one year after the date of grant.
Exercisable date, exercise date, exercise price, purchase price, sales price, and/or expiration date is/are not applicable in this case.
The stock option award vests in four equal annual installments, commencing one year after the date of grant.
/s/**Douglas McCorkle
2012-12-18